In a perplexing conclusion to an oftentimes tense meeting of the CDC’s Advisory Committee on Immunization Practices (ACIP) ...

The duel of the GLP-1 data sets continues this week, with Novo issuing the latest salvo of updates on its oral obesity ...

With both companies on an upward trajectory, argenx and its manufacturing partner Fujifilm Biotechnologies are taking a ...

Nearly three years after originating the role, Erica Taylor, Ph.D., is stepping down as chief marketing officer of Genentech.

MilliporeSigma, a unit of Germany's Merck KGaA, opened a 150 million euro ($177 million) filtration products plant in Cork, ...

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with type 2 diabetes. | Over the last six years, three GLP-1 drugs have been approved for children aged 10 ...

Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity. | Bluebird bio has molted to reveal a new—or new-ish, at least—brand identity.

X4 Pharmaceuticals is again shrinking its workforce, this time by 50% as the company pushes to save costs and finish a phase ...

Novo Nordisk is not wasting time beginning the layoffs it announced last week as part of a major restructuring effort. The ...

Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...

That’s according to Will Reese, chief innovation officer at Inizio Evoke, who spoke with Fierce Pharma Marketing during last ...

SK Biopharmaceutical’s Xcopri (cenobamate) met the bar in a phase 3 trial that could support the company’s ambitions of ...